Expression of matrix metalloproteinases in ovarian endometriomas: Immunohistochemical study and enzyme immunoassay

Life Sciences

Volumn 71, Issue 3, 2002, Pages 259-273

  Mizumoto, Hisanobu ^a   Saito, Tsuyoshi ^a   Ashihara, Koji ^a   Nishimura, Makoto ^a   Takehara, Masaki ^a   Tanaka, Ryoichi ^a   Ito, Eiki ^a   Kudo, Ryuichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Endometrioma; Endometriosis; Immunohistochemistry; Menstrual cycle; MMP

Indexed keywords

GELATINASE A; GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; ENDOMETRIOSIS; ENZYME IMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; EXTRACELLULAR SPACE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MENSTRUAL CYCLE; OVARY TUMOR; PROTEIN EXPRESSION; WESTERN BLOTTING;

BLOTTING, WESTERN; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASES; MENSTRUAL CYCLE; OVARIAN NEOPLASMS;

EID: 0037036174     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(02)01641-7     Document Type: Article

References (34)

1. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells
2. Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma
3. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form
4. Invasiveness corresponds to differentiation rather than to proteinase secretion in endometrial cancer cell lines
5. Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
6. Expression of messenger ribonucleic acid encoding matrix metalloproteinases and their tissue inhibitors is related to menstruation
7. Matrix metalloproteinase production by cultured human endometrial stromal cells: Identification of interstitial collagenase, gelatinase-A, gelatinase-B, and stromelysin-1 and their differential regulation by interleukin-1 alpha and tumor necrosis factor-alpha
8. Focal cellular origin and regulation of interstitial collagenase (matrix metalloproteinase-1) are related to menstrual breakdown in the human endometrium
9. Production of matrix metalloproteinase 3 (stromelysin) by cultured ovine endometrial cells
10. Expression and localization of matrilysin, a matrix metalloproteinase, in human endometrium during the reproductive cycle
11. Ovarian steroid-modulated stromelysin-1 expression in human endometrial stromal and decidual cells
12. Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation
13. Cytokine-mediated regulation of 92-kilodalton type IV collagenase, tissue inhibitor or metalloproteinase-1 (TIMP-1), and TIMP-3 messenger ribonucleic acid expression in human endometrial stromal cells
14. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin-1 alpha and its dual block by ovarian steroids
15. Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium
16. Human endometrial matrix metalloproteinase-2, a putative menstrual proteinase. Hormonal regulation in cultured stromal cells and messenger RNA expression during the menstrual cycle
17. Matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-3 mRNA expression in ectopic and eutopic endometrium in women with endometriosis: A rationale for endometriotic invasiveness
18. Matrix metalloproteinases and TACE play a role in the pathogenesis of endometriosis
19. Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants
20. Induction of cell transformation by mutated 16 K vacuolar H+-atpase (ductin) is accompanied by down-regulation of gap junctional intercellular communication and translocation of connexin 43 in NIH3T3 cells
21. Progesterone exposure prevents matrix metalloproteinase-3 (MMP-3) stimulation by interleukin-1alpha in human endometrial stromal cells
22. Matrix metalloproteinase and matrix metalloproteinase inhibitor expression in endometrial stromal cells during progestin-initiated decidualization and menstruation-related progestin withdrawal
23. Matrix metalloproteinases in normal menstruation
24. Production of matrix metalloproteinase 1 (interstitial collagenase) and matrix metalloproteinase 2 (gelatinase A: 72 kDa gelatinase) by ovine endometrial cells in vitro: Different regulation and preferential expression by stromal fibroblasts
25. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis
26. Expression of estrogen and progesterone receptors and their mRNAs in ovarian endometriosis
27. Increased chemotactic activity of peritoneal fluid in patients with endometriosis
28. Peritoneal fluid concentrations of the cytokine RANTES correlate with the severity of endometriosis
29. Immunohistochemical localization of granulocyte-macrophage colony-stimulating factor in matched endometriosis and endometrial tissues
30. Expression of interstitial collagenase (matrix metalloproteinase-1) is related to the activity of human endometriotic lesions
31. Expression of MMP-3 and TIMP-1 in the endometriosis and the influence of danazol
32. The putative role of cell adhesion molecules in endometriosis: Can we learn from tumour metastasis?
33. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer